Koers Mateon Therapeutics Inc OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2022 | - | Omzet 2023 | 0,07 0,06 | Marktkapitalisatie | 15,27 mln. 14,18 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 5 mln. 4,64 mln. | Nettowinst (verlies) 2023 | -7 mln. -6,5 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 11,02 mln. 10,23 mln. | Nettoschuld 2023 | 12,4 mln. 11,52 mln. | EV/omzet 2023 | 395.316.686 x |
K/w-verhouding 2022 |
4,5
x | K/w-verhouding 2023 |
-1,91
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 45,03% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vuong Trieu
CEO | Chief Executive Officer | 59 | 22-04-19 |
Director of Finance/CFO | 57 | 01-07-19 | |
Seymour H. Fein
CTO | Chief Tech/Sci/R&D Officer | 75 | 06-01-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven King
BRD | Director/Board Member | 59 | 11-05-20 |
Anthony Maida
CTO | Chief Tech/Sci/R&D Officer | 59 | 11-05-20 |
Vuong Trieu
CEO | Chief Executive Officer | 59 | 22-04-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
+1,28% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-7,05% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |
- Beurs
- Aandelen
- Koers OTLC
- Koers